IVF regulation stories

Sep 21, 2026

China regulators slow humanoid robot IPO rush amid valuation concerns

Chinese regulators are putting the brakes on a wave of humanoid robot companies seeking public listings, scrutinizing whether soaring valuations and revenue tied to state-backed projects reflect genuine commercial demand. Global humanoid robot sales reached 7,000 units last year.

Sep 21, 20262 sources

Jun 10, 2026

Senator Elizabeth Warren Calls on SEC to Delay SpaceX IPO Over Governance and Valuation Concerns

Senator Elizabeth Warren urged the Securities and Exchange Commission to pause SpaceX's initial public offering, citing potential risks to retail investors from valuation and governance issues. The request came one day before order books closed on what would be the largest listing in history.

Jun 10, 20264 sources

Top claims

▪Mech-Mind Robotics CEO Shao Tianlan alleged in a WeChat post this month that some highly valued embodied-AI firms racing toward IPOs generated unsustainable revenue through data collection centers and related-party deals
▪An investor estimate suggests valuations at some robot companies could fall 60% to 70% if revenue from government-backed data-collection centers is excluded
▪International Federation of Robotics Secretary General Susanne Bieller stated that many humanoid robots sold in 2025 were used by research institutions to generate AI training data

Subtopics

China tech & industrial strategy1 Corporate governance1 Elizabeth Warren1 Humanoid robotics1 Investor protection1 Securities regulation1

Related timelines